Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 53 Records) |
Query Trace: Glioma and IDH2[original query] |
---|
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients. Acta neuropathologica communications 2015 3 (1): 88. Draaisma Kaspar, Wijnenga Maarten M J, Weenink Bas, Gao Ya, Smid Marcel, Robe P, van den Bent Martin J, French Pim |
Prevalence of IDH1/2 Mutations in Different Subtypes of Glioma in the North-East Population of Morocco. Asian Pacific journal of cancer prevention : APJCP 2016 17 (5): 2649-53. Senhaji Nadia, Louati Sara, Chbani Laila, Bardai Sanae El, Mikou Karima, Maaroufi Mustafa, Benzagmout Mohammed, Faiz Mohammed Chaoui El, Marie Yannick, Mokhtari Karima, Idbaih Ahmed, Amarti Afaf, Bennis San |
Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro-oncology 2016 Jun . Zhang Biqi, Chang Ken, Ramkissoon Shakti, Tanguturi Shyam, Bi Wenya Linda, Reardon David A, Ligon Keith L, Alexander Brian M, Wen Patrick Y, Huang Raymond |
Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma. The oncologist 2016 Feb . Fathi Amir T, Nahed Brian V, Wander Seth A, Iafrate A John, Borger Darrell R, Hu Ranliang, Thabet Ashraf, Cahill Daniel P, Perry Ashley M, Joseph Christelle P, Muzikansky Alona, Chi Andrew |
A new functional IDH2 genetic variant is associated with the risk of lung cancer. Molecular carcinogenesis 2016 Sep . Li Jiangjiang, Lu Jingchen, He Ya, Wu Yong, Wu Yuan, Song Xin, Jiang Yuee, Tang Min, Weng Xinxian, Yi Wei, Luo Xiangjian, Sun Lunquan, Bode Ann M, Cao |
IDH mutation is associated with higher risk of malignant transformation in low-grade glioma. Journal of neuro-oncology 2016 Jan . Leu Severina, von Felten Stefanie, Frank Stephan, Boulay Jean-Louis, Mariani Lui |
Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis. World neurosurgery 2017 Dec . Phan Kevin, Ng Wyatt, Lu Victor M, McDonald Kerrie L, Fairhall Jacob, Reddy Rajesh, Wilson Pet |
IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy. Epilepsy & behavior : E&B 2017 11 78 30-36. Neal Andrew, Kwan Patrick, O'Brien Terence John, Buckland Michael E, Gonzales Michael, Morokoff Andr |
Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2017 30 (5): 361-371. Houdova Megova M, Drábek J, Dwight Z, Trojanec R, Koudeláková V, Vrbková J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch |
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population. Biomedica : revista del Instituto Nacional de Salud 2018 6 38 (0): 86-92. Ricaurte Orlando, Neita Karina, Valero Danyela, Ortega-Rojas Jenny, Arboleda-Bustos Carlos E, Zubieta Camilo, Penagos José, Arboleda Gonza |
Overexpression of Fn14 in gliomas: tumor progression and poor prognosis. Future oncology (London, England) 2018 5 14 (13): 1273-1284. Tan Dan, Pang Feng-Mei, Li Dan, Zhang Longbo, Wu Jun, Liu Zhao-Qian, Li Xi, Yan H |
Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (12): 2812-2819. Martínez-Ricarte Francisco, Mayor Regina, Martínez-Sáez Elena, Rubio-Pérez Carlota, Pineda Estela, Cordero Esteban, Cicuéndez Marta, Poca Maria A, López-Bigas Nuria, Ramon Y Cajal Santiago, Vieito María, Carles Joan, Tabernero Josep, Vivancos Ana, Gallego Soledad, Graus Francesc, Sahuquillo Juan, Seoane Jo |
IDH Mutation Analysis in Glioma Patients by CADMA Compared with SNaPshot Assay and two Immunohistochemical Methods. Pathology oncology research : POR 2018 3 25 (3): 971-978. Urbanovska Irena, Megova Magdalena Houdova, Dwight Zachary, Kalita Ondrej, Uvirova Magdalena, Simova Jarmila, Tuckova Lucie, Buzrla Petr, Palecek Tomas, Hajduch Marian, Dvorackova Jana, Drabek Ji |
Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1) in brain tumors of a cohort of Italian patients. Scientific reports 2018 Mar 8 (1): 4459. Acquaviva Giorgia, Visani Michela, de Biase Dario, Marucci Gianluca, Franceschi Enrico, Tosoni Alicia, Brandes Alba A, Rhoden Kerry J, Pession Annalisa, Tallini Giovan |
TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis. Journal of neuropathology and experimental neurology 2020 Jan . Hewer Ekkehard, Phour Jaison, Gutt-Will Marielena, Schucht Philippe, Dettmer Matthias S, Vassella Er |
Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients. Journal of neurosurgery 2020 2 134 (3): 733-741. Ishi Yukitomo, Yamaguchi Shigeru, Hatanaka Kanako C, Okamoto Michinari, Motegi Hiroaki, Kobayashi Hiroyuki, Terasaka Shunsuke, Houkin Kiyohi |
Variable expression of CXCR4 in molecular subtypes of infiltrating gliomas. Clinical neuropathology 2020 Dec . Dono Antonio, Zhu Ping, Zorofchian Soheil, Takayasu Takeshi, Quezado Martha M, Rios Adan, Powers Astin, Esquenazi Yoshua, Ballester Leomar |
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation. Journal of neuro-oncology 2020 Nov . Poetsch L, Bronnimann C, Loiseau H, Frénel J S, Siegfried A, Seizeur R, Gauchotte G, Cappellen D, Carpentier C, Figarella-Branger D, Eimer S, Meyronet D, Ducray F, |
EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma. Oncology letters 2020 Dec 20 (6): 384. Taher Mohiuddin M, Dairi Ghida, Butt Ejaz Muhammad, Al-Quthami Khalid, Al-Khalidi Hisham, Jastania Raid A, Nageeti Tahani H, Bogari Neda M, Athar Mohammad, Al-Allaf Faisal A, Valerie Kristoff |
Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021 8 10 (8): . Murnyak Balazs, Huang L Er |
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 6 27 (16): 4491-4499. Mellinghoff Ingo K, Penas-Prado Marta, Peters Katherine B, Burris Howard A, Maher Elizabeth A, Janku Filip, Cote Gregory M, de la Fuente Macarena I, Clarke Jennifer L, Ellingson Benjamin M, Chun Saewon, Young Robert J, Liu Hua, Choe Sung, Lu Min, Le Kha, Hassan Islam, Steelman Lori, Pandya Shuchi S, Cloughesy Timothy F, Wen Patrick |
Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy. Cancer genetics 2022 9 268-269 55-63. Husain Adil, Mishra Sridhar, Hadi Rahat, Sahu Avnish, Kumari Swati, Rastogi Madhup, Khurana Rohini, Shukla Saumya, Siddiqui Mohammed Haris, Husain Nuzh |
A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
Plk1 regulates mutant IDH1 enzyme activity and mutant IDH2 ubiquitination in mitosis. Cellular signalling 2022 2 92 110279. Saikiran Reddy M, Bhattacharjee Debanjan, Jain Nisha |
Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors. Genes 2022 11 13 (11): . Schenkel Laila C, Mathew Joseph, Hirte Hal, Provias John, Paré Guillaume, Chong Michael, Grafodatskaya Daria, McCready Elizabe |
Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients. Pakistan journal of medical sciences 2023 5 39 (3): 843-847. Xipeng Liu, Ming Liu, Bing Cao, Jianxin Qiao, Xiufeng Zha |
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
Clinical outcome, radiological findings, and genetic features of IDH-mutant brainstem glioma in adults. Acta neurochirurgica 2024 6 166 (1): 263. Sogo Oki, Yukitomo Ishi, Ryosuke Sawaya, Michinari Okamoto, Hiroaki Motegi, Zen-Ichi Tanei, Masumi Tsuda, Takashi Mori, Kentaro Nishioka, Hiromi Kanno-Okada, Hidefumi Aoyama, Shinya Tanaka, Shigeru Yamaguchi, Miki Fujimu |
Rapid Tumor DNA Analysis of Cerebrospinal Fluid Accelerates Treatment of Central Nervous System Lymphoma. Blood 2024 5 . Mihir Gupta, Joseph Bradley, Elie Massaad, Evan Burns, N Zeke Georgantas, Garrett Maron, Julie Batten, Aidan Gallagher, Julia Thierauf, Naema Nayyar, Amanda Gordon, SooAe Jones, Michelle Pisapia, Ying Sun, Pamela Stuart Jones, Fred G Barker, William Curry, Rajiv Gupta, Javier Romero, Nancy Wang, Priscilla Brastianos, Maria Martinez-Lage, Kensuke Tateishi, Deborah Anne Forst, Brian Vala Nahed, Tracy T Batchelor, Lauren L Ritterhouse, Florian Iser, Tobias Kessler, Justin T Jordan, Jorg Dietrich, Matthew L Meyerson, Daniel P Cahill, Jochen K Lennerz, Bob Carter, Ganesh M Shank |
- Page last reviewed:Feb 1, 2024
- Content source: